Next-Generation Hemp Extracts and Compositions

Publication ID: 24-11857590_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Hemp Extracts and Compositions,” Published Technical Disclosure No. 24-11857590_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857590_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,590.

Summary of the Inventive Concept

A novel, AI-driven hemp extract production system that leverages machine learning, IoT, and blockchain technologies to create personalized, adaptive formulations, neuron-targeted therapeutics, and modular cultivation platforms, revolutionizing the hemp industry.

Background and Problem Solved

The original patent, 'Systems and methods for producing hemp extracts and compositions', provides a foundation for hemp extract production, but it has limitations in terms of customization, scalability, and therapeutic efficacy. The new inventive concept addresses these limitations by integrating cutting-edge technologies to create a more efficient, effective, and patient-centric approach.

Detailed Description of the Inventive Concept

The new inventive concept consists of four key components: 1) a database-driven system for generating personalized hemp extract formulations, 2) a CRISPR-Cas9 gene editing approach for enhancing CBD's neuroprotective effects, 3) a modular, AI-driven hemp cultivation platform with IoT-enabled grow modules and predictive analytics, and 4) a hemp-derived, bio-absorbable implantable device for sustained release of cannabinoids. These components work in tandem to create a seamless, data-driven production process that prioritizes patient needs and optimizes therapeutic outcomes.

Novelty and Inventive Step

The new inventive concept's integration of AI, IoT, blockchain, and gene editing technologies represents a significant departure from the original patent's methods. The use of machine learning algorithms to predict optimal extract compositions, CRISPR-Cas9 gene editing to enhance CBD's neuroprotective effects, and modular cultivation platforms with predictive analytics are all novel and non-obvious advancements that overcome the limitations of the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of other gene editing tools, such as TALEN or ZFN, or the integration of additional AI-powered modules for real-time quality control and supply chain management. Variations of the cultivation platform could incorporate different types of sensors or automation systems to optimize crop yields and reduce waste.

Potential Commercial Applications and Market

The new inventive concept has far-reaching commercial potential in the hemp industry, with applications in personalized medicine, pharmaceuticals, and nutraceuticals. The target market includes healthcare providers, pharmaceutical companies, and consumers seeking more effective and targeted hemp-based products.

CPC Classifications

SectionClassGroup
A A61 A61K36/185
A A61 A61K31/05
A A61 A61K2236/31
A A61 A61K2236/331
A A61 A61K2236/333
A A61 A61K2236/35
A A61 A61K2236/37
A A61 A61K2236/53
A A61 A61K2236/55

Field of Art

Cannabinoid extraction, pharmaceutical composition development, and biotechnology with a focus on hemp-derived medical treatments, requiring advanced knowledge in organic chemistry, biochemistry, pharmaceutical engineering, and biotechnology

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees (MS/PhD) in chemistry, biochemistry, or pharmaceutical sciences, with expertise in extraction techniques, cannabinoid processing, biotechnology methods, and familiarity with emerging technologies in medical product development

Obviousness Rationale

A PHOSITA would recognize that the PTD's disclosed variations represent predictable technological extensions of the source patent's hemp extraction methods, leveraging known techniques in AI, gene editing, and personalized medicine to enhance cannabinoid production and therapeutic targeting. The integration of machine learning, IoT, and gene editing technologies represents a natural progression of existing hemp extract development methodologies. These variations demonstrate incremental improvements using standard interdisciplinary approaches that would be apparent to a skilled practitioner in the field.

Obvious Combinations & Variations

Source Patent Element
Hemp extract production method using specific solvent mixtures and extraction temperatures
PTD Variation
AI-driven system for generating personalized hemp extract formulations using machine learning algorithms
Obviousness Reasoning
Predictable application of computational techniques to optimize existing extraction processes, representing a known approach in pharmaceutical development for creating targeted therapeutic compositions
Source Patent Element
Cannabis plant material processing for therapeutic compositions
PTD Variation
CRISPR-Cas9 gene editing to enhance CBD's neuroprotective effects
Obviousness Reasoning
Routine application of contemporary genetic modification techniques to improve cannabinoid properties, utilizing well-established molecular biology methods known in the biotechnology field
Source Patent Element
Methods for producing full spectrum hemp extracts
PTD Variation
IoT-enabled modular cultivation platform with predictive analytics for hemp crop optimization
Obviousness Reasoning
Logical extension of existing agricultural and extraction technologies, applying standard industrial automation and data analysis techniques to improve hemp production processes
Source Patent Element
Cannabinoid extraction and concentration techniques
PTD Variation
Bio-absorbable implantable device for sustained cannabinoid release using 3D printing
Obviousness Reasoning
Conventional pharmaceutical engineering approach of creating controlled-release drug delivery systems, applying known biomaterials and fabrication techniques to cannabinoid therapeutics
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857590 and the disclosed technological variations, a person of ordinary skill in the art would find the claimed innovations obvious and lacking inventive step. The published technical disclosure demonstrates that the proposed methods represent predictable combinations of known techniques in cannabinoid extraction, biotechnology, and personalized medicine, thereby rendering subsequent claims of novelty invalid under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,590
TitleSystems and methods for producing hemp extracts and compositions
Assignee(s)Ecofibre Limited